Clinical Study of KW-2246 in Patients With Cancer Pain
NCT00355628 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2012-08-31
Summary
This study is a Phase II open-label study to investigate the recommended conversion ratio (oral morphine dose to KW-2246) when switching oral morphine or oxycodone to KW-2246 in cancer patients.
Conditions
Interventions
- DRUG
-
KW-2246 (fentanyl citrate)
KW-2246
Sponsors & Collaborators
-
Kyowa Kirin Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Study Director · Kyowa Kirin Co., Ltd.
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2007-07-31
Countries
- Japan
Study Locations
More Related Trials
-
Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain
NCT05962294 ·Status: UNKNOWN
-
A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion
NCT00626600 ·Status: TERMINATED ·Phase: PHASE3
-
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
NCT00911261 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
NCT00216658 ·Status: COMPLETED ·Phase: PHASE2
-
An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.
NCT02660229 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
NCT03176121 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
NCT00262678 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient
NCT01482936 ·Status: COMPLETED ·Phase: PHASE1
-
Immediate-Release Oxycodone Capsules Study in Cancer Pain
NCT01675622 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy
NCT00904280 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain
NCT00641667 ·Status: COMPLETED ·Phase: PHASE3
-
Analgesic Treatment for Cancer Pain in South East Asia
NCT02664987 ·Status: COMPLETED
-
A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer
NCT00943566 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain
NCT02084355 ·Status: UNKNOWN ·Phase: PHASE3
-
Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain
NCT02382653 ·Status: COMPLETED ·Phase: NA
-
An Observation Study to Assess the Efficacy and Safety of Proportional Doses of Painkyl® in Patients With Breakthrough Cancer Pain
NCT05209906 ·Status: COMPLETED
-
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
NCT01885182 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Fentanyl TAIFUN Treatment
NCT00822614 ·Status: UNKNOWN ·Phase: PHASE3
-
Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain
NCT04533243 ·Status: UNKNOWN ·Phase: PHASE3
-
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02321397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain
NCT00378937 ·Status: COMPLETED ·Phase: PHASE4
-
Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain
NCT00478101 ·Status: COMPLETED ·Phase: PHASE2
-
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
NCT00666211 ·Status: COMPLETED ·Phase: PHASE3
-
Nasal Fentanyl for Patient Controlled Treatment of Pain in Cancer
NCT01248611 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder.
NCT01809106 ·Status: COMPLETED ·Phase: PHASE4